Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Obstructive Lung Diseases

Free Subscription 19.05.2025 2 Allergy 1 Am J Med 3 Ann Allergy Asthma Immunol 3 Arch Bronconeumol 2 BMC Pediatr 3 Chest 1 Eur Respir J 3 J Asthma 1 Pediatr Allergy Immunol 1 PLoS Med 5 PLoS One 3 Pneumologie 10 Respir Med 2 Respir Res 1 Rev Mal Respir

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Allergy

1. GATES J, Haris F, Cefaloni F, Khooshemehri P, et al
   Clinical and Biological Remission With Tezepelumab: The Real-World Response in Severe Uncontrolled Asthma.
   Allergy. 2025 May 14. doi: 10.1111/all.16590.
   PubMed         Abstract available
   
   
2. LESKIEN M, Thiering E, Yu Z, Huels A, et al
   Childhood Asthma and Allergy Are Related to Accelerated Epigenetic Aging.
   Allergy. 2025 May 10. doi: 10.1111/all.16583.
   PubMed         Abstract available
   
   

   
   Am J Med

3. PAIDA E, Sapouridis G, Karypidou E, Simoulidou E, et al
   Emphysematous hepatitis and septic pylephlebitis caused by Gram negative bacteremia.
   Am J Med. 2025 May 8:S0002-9343(25)00292-X. doi: 10.1016/j.amjmed.2025.
   PubMed        
   
   

   
   Ann Allergy Asthma Immunol

4. KIM Y, Moonie S, Kim I, Yoo JW, et al
   Increasing trend in asthma hospitalization among cannabis-dependent abusers and recreational cannabis legalizations (1998-2021).
   Ann Allergy Asthma Immunol. 2025 May 11:S1081-1206(25)00232.
   PubMed        
   
   
5. DOWLING TC, Shah MM, Moulia DL, Hsu J, et al
   Recommended immunizations to reduce respiratory morbidity and mortality among US adults with asthma, by age.
   Ann Allergy Asthma Immunol. 2025;134:535-538.
   PubMed        
   
   
6. MURAI Y, Koya T, Koda H, Uji W, et al
   Dupilumab efficacy in relation to changes in club cell secretory protein 16.
   Ann Allergy Asthma Immunol. 2025;134:556-562.
   PubMed         Abstract available
   
   

   
   Arch Bronconeumol

7. GOLPE R, Veiga I, Dacal-Rivas D, Blanco-Cid N, et al
   Blood Eosinophil Count During Severe Bronchiectasis Exacerbation and Risk of Hospital Readmission.
   Arch Bronconeumol. 2025 May 1:S0300-2896(25)00156.
   PubMed        
   
   
8. DACAL RIVAS D, Martinez-Moragon E, Plaza V, Cisneros Serrano C, et al
   Early Failure, Late Failure, and Sustained Response to Biologics in Severe Asthma: A Long-term, Real-world, Multicentre study.
   Arch Bronconeumol. 2025 Apr 26:S0300-2896(25)00139.
   PubMed         Abstract available
   
   
9. MAROTO E, Esteban Lombarte MDM, Garriga-Baraut T, Garcia Del Cerro G, et al
   Efficacy of a Digitally Supported Intervention for Children and Adolescents With Difficult-to-control Asthma (INSPIRINGKIDS): Results From a Multicentre Randomized Controlled Trial.
   Arch Bronconeumol. 2025 Apr 28:S0300-2896(25)00140.
   PubMed        
   
   

   
   BMC Pediatr

10. ABDULWAHAB MASOOD H, Mohammed Othman A, Nasr Addin Al-Sonboli N, Abdulnoor Ghlab F, et al
    Association of STAT6 gene polymorphism with atopic asthma among Yemeni children in Sana'a city, Yemen.
    BMC Pediatr. 2025;25:386.
    PubMed         Abstract available
    
    
11. SEOL JH, Eun LY, Lee JH
    Long-term risk of allergic disorders following Kawasaki disease: a population-based cohort study.
    BMC Pediatr. 2025;25:380.
    PubMed         Abstract available
    
    

    
    Chest

12. FENG Z, Li G, He Q, Sun N, et al
    Associations of Socioeconomic Status and Phenotypic Frailty With Incident COPD: Findings From UK Biobank Participants.
    Chest. 2025;167:1321-1332.
    PubMed         Abstract available
    
    
13. CELLI BR, Anzueto A, Singh D, Hanania NA, et al
    The Emerging Role of Alarmin-Targeting Biologics in the Treatment of Patients With COPD.
    Chest. 2025;167:1346-1355.
    PubMed         Abstract available
    
    
14. YILMAZ I, Turk M
    Differences in Expert Opinion on Selection of Initial Biologics and Biologic Switching in Severe Asthma.
    Chest. 2025;167:e167.
    PubMed        
    
    

    
    Eur Respir J

15. GIRAULT A, Le A, Gonsard A, Abou Taam R, et al
    ChatGPT and Other Large Language Models for Parents' Questions About Childhood Asthma: A Comparative Study.
    Eur Respir J. 2025 May 15:2500254. doi: 10.1183/13993003.00254-2025.
    PubMed        
    
    

    
    J Asthma

16. BAYIROGLU F, Erdonmez N, Aydin L, Kaya MS, et al
    Enhancing the Nutraceutical and Nutritional Features of Wheat Germ to Reduce Atopic Asthma Symptoms in Children.
    J Asthma. 2025 May 15:1-12. doi: 10.1080/02770903.2025.2499833.
    PubMed         Abstract available
    
    
17. ZOUEIN J, Que LG, Ingram JL
    Obesity-driven airway eosinophilia and neutrophilia in asthma.
    J Asthma. 2025 May 15:1-15. doi: 10.1080/02770903.2025.2505464.
    PubMed         Abstract available
    
    
18. LI Y, Wang Z, Zhu H, Yang S, et al
    Jian'er Qiangshen Ointment Treating Bronchial Asthma by Inhibiting Lung Inflammation and Regulating Intestinal Microbiota.
    J Asthma. 2025 May 14:1-20. doi: 10.1080/02770903.2025.2505462.
    PubMed         Abstract available
    
    

    
    Pediatr Allergy Immunol

19. COMOTTI A, Alberti I, Spolidoro GCI, Vassilopoulou E, et al
    Air pollution and hospitalization risk in infants with bronchiolitis: A systematic review and meta-analysis.
    Pediatr Allergy Immunol. 2025;36:e70102.
    PubMed         Abstract available
    
    

    
    PLoS Med

20. DEMKOWICZ BJ, Rader K, Wang SV, Kesselheim AS, et al
    The comparative effectiveness and safety of fluticasone-salmeterol via metered-dose versus dry powder inhalers for COPD: A new user cohort study.
    PLoS Med. 2025;22:e1004596.
    PubMed         Abstract available
    
    

    
    PLoS One

21. ZHANG Q, Zhou L, Yuan L, Zhang R, et al
    scRNA-seq and scATAC-seq analyses highlight the role of TNF signaling pathway in chronic obstructive pulmonary disease model mice.
    PLoS One. 2025;20:e0322538.
    PubMed         Abstract available
    
    
22. VETTLESON-TRUTZA SA, Pazdernik VK, Skalski JH, Snyder MR, et al
    Evolving demographics of eligible patient population can impact enrollment of a biomarker clinical study.
    PLoS One. 2025;20:e0323187.
    PubMed         Abstract available
    
    
23. SANCHEZ CODEZ MI, Benavente Fernandez I, Moyer K, Leber AL, et al
    The differential burden of acute rhinovirus infections in children with underlying conditions.
    PLoS One. 2025;20:e0313237.
    PubMed         Abstract available
    
    
24. RUSSELL ST, Kang M, Kempker JA
    An updated comparison of standard and novel FEV1 indices' association with all-cause mortality.
    PLoS One. 2025;20:e0323681.
    PubMed         Abstract available
    
    
25. MA X, Jian S, Hou E, Wei Y, et al
    Social determinants of health on all-cause and cause-specific mortality in US adults with chronic obstructive pulmonary disease: NHANES 2005-2018.
    PLoS One. 2025;20:e0322654.
    PubMed         Abstract available
    
    

    
    Pneumologie

26. PUSCHNER F, Schiller J, Urbanski-Rini D, Scholl K, et al
    [TELEMEdical moNiTORing for COPD patients (Telementor COPD): Study protocol of a multicentre, randomised, controlled study].
    Pneumologie. 2025;79:358-365.
    PubMed         Abstract available
    
    
27. BEEH KM, Kruger S
    [Use of long-acting triple therapy for chronic obstructive pulmonary disease (COPD) in practice: The ELETHON physicians' survey].
    Pneumologie. 2025;79:366-376.
    PubMed         Abstract available
    
    
28. STIEGLITZ S, Frohnhofen H
    [COPD in elderly patients].
    Pneumologie. 2025;79:382-394.
    PubMed         Abstract available
    
    

    
    Respir Med

29. MATTA A, Polychronopoulou E, Kuo YF, Sharma G, et al
    Pulmonary rehabilitation utilization in patients with chronic respiratory diseases: 2014-2019.
    Respir Med. 2025;242:108110.
    PubMed         Abstract available
    
    
30. LIGUORO I, Patui M, Vidoni M, Pilotto C, et al
    Comparison of the sensitivity and specificity of bronchiolitis severity scores in infants: a systematic review and meta-analysis.
    Respir Med. 2025;242:108111.
    PubMed         Abstract available
    
    
31. BENFANTE A, Tomasello A, Pitruzzella A, Fucarino A, et al
    Exploring a novel approach to COPD treatment: benralizumab effect in an ex vivo 3-D model.
    Respir Med. 2025;242:108107.
    PubMed         Abstract available
    
    
32. GHERASIM A, Dietsch F, Odul F, Riff T, et al
    Efficacy of air cleaners to reduce allergic responses to cat: a randomized clinical trial using an environmental exposure chamber.
    Respir Med. 2025 Apr 15:108105. doi: 10.1016/j.rmed.2025.108105.
    PubMed         Abstract available
    
    
33. JALALVAND M, Tahermohammadi H, Madreseh E, Varahram M, et al
    Regulatory T cells in the blood of patients with chronic obstructive pulmonary disease (COPD): A systematic review and meta-analysis.
    Respir Med. 2025;242:108104.
    PubMed         Abstract available
    
    
34. FANDOS VAZQUEZ P, Diez-Manglano J
    Thyroid hormones in people with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2025;242:108103.
    PubMed         Abstract available
    
    
35. PIERRE C, Jeanne I, Mathieu B, Hugo G, et al
    Characteristics and risk factors of intubation in COPD patients with severe acute exacerbation: An exploratory single-center retrospective study.
    Respir Med. 2025;242:108095.
    PubMed         Abstract available
    
    
36. MOERMANS C, Decerf N, Javaux N, Onssels A, et al
    High local type-2 inflammation is linked to response in severe asthma treated with anti-Interleukin-5 receptor.
    Respir Med. 2025 May 7:108151. doi: 10.1016/j.rmed.2025.108151.
    PubMed         Abstract available
    
    
37. LEMACON C, Lopes AA
    Inhalers or nebulisation of salbutamol in childhood asthma exacerbations in emergency departments.
    Respir Med. 2025 May 8:108152. doi: 10.1016/j.rmed.2025.108152.
    PubMed         Abstract available
    
    
38. XIANG J, Cui M
    Neutrophil Extracellular Traps and neutrophilic asthma.
    Respir Med. 2025 May 12:108150. doi: 10.1016/j.rmed.2025.108150.
    PubMed         Abstract available
    
    

    
    Respir Res

39. LI W, Yang Q, Chen Y, Sun Y, et al
    Angiotensin receptor blockers use and lung cancer risk in Chinese patients with chronic obstructive pulmonary disease: a population-based cohort study.
    Respir Res. 2025;26:186.
    PubMed         Abstract available
    
    
40. ZHAO L, Wu W, Chen G, Huang C, et al
    SERPINB10 promotes macrophage M2 polarization and airway inflammation in asthma.
    Respir Res. 2025;26:181.
    PubMed         Abstract available
    
    

    
    Rev Mal Respir

41. GROSZ T, Calcaianu G, Palpacuer C, Riou M, et al
    [Evaluation of compliance with prescription proposals for COPD in the Alsace region of France].
    Rev Mal Respir. 2025;42:243-251.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.